About
Profile
Headquarters
Intraday
High
-
Low
-
52-week
High
-
Low
-
LGND
...
Available for logged in users only.
The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.
Contact us via Twitter if you are interested in trying it out.
- Ligand Pharmaceuticals Non-GAAP EPS of $1.05 beats by $0.39, revenue of $28.1M beats by $2.46M
- Ligand Pharmaceuticals Q4 2023 Earnings Preview
- Esai gets Japanese approval for epilepsy drug using Ligand technology
- Small cap value stocks with potential M&A candidacy - BofA
- Johnson & Johnson posts Q4 beat as pharma and MedTech outperform
- FDA approves Ligand's Zelsuvmi for treatment of molluscum
- Ligand Pharmaceuticals Non-GAAP EPS of $1.02 beats by $0.40, revenue of $32.87M beats by $5.65M
- Ligand Pharmaceuticals Q3 2023 Earnings Preview
- Ligand acquires royalty on Sanofi’s TZIELD for $20 million
- Ligand Pharmaceuticals acquires 13% of soticlestat royalties from Ovid Therapeutics for $30M
- Morgan Stanley: 81 companies will have technical pressures due to tax loss selling
- Ligand Pharmaceuticals closes acquisition of assets of Novan
- Ligand Pharmaceuticals' CEO Davis Todd increases shareholding
- Ligand spins out Pelican unit as separate company, updates guidance
- Ligand Pharmaceuticals Non-GAAP EPS of $1.42 beats by $0.76, revenue of $26.4M beats by $0.67M
- Ligand Pharmaceuticals Q2 2023 Earnings Preview
- Novan craters as company files for bankruptcy, to sell most of its assets
- Ligand Pharma up 5% after hours on 2023 guidance boosts
- Ligand Pharmaceuticals Non-GAAP EPS of $2.28 beats by $1.39, revenue of $43.9M beats by $10.35M
- Ligand Pharmaceuticals Q1 2023 Earnings Preview
Date | Price | Open | High | Low | Vol | Change | ER | |||
---|---|---|---|---|---|---|---|---|---|---|
Mar 4 | 96.92 | 99.51 |
101.10
|
96.40
|
188.00K | -4% | ||||
Mar 3 | 100.96 | 103.10 |
103.72
|
99.51
|
143.69K | -1.37% | ||||
Mar 2 | 102.36 | 97.83 |
104.18
|
97.37
|
134.96K | 4.66% | ||||
Mar 1 | 97.80 | 100.46 |
102.27
|
96.79
|
242.33K | -3.38% | ||||
Feb 28 | 101.22 | 99.79 |
103.83
|
99.79
|
144.58K | 0.17% | ||||
Feb 25 | 101.05 | 103.16 |
103.42
|
99.76
|
192.35K | -2.4% | ||||
Feb 24 | 103.53 | 92.87 |
104.18
|
88.50
|
209.74K | 8.99% | ||||
Feb 23 | 94.99 | 99.00 |
100.65
|
94.83
|
317.17K | -3.48% | ||||
Feb 22 | 98.41 | 101.08 |
101.75
|
98.25
|
295.48K | -4.05% | ||||
Feb 18 | 102.56 | 109.25 |
109.25
|
99.01
|
459.17K | -8.6% | ||||
Feb 17 | 112.21 | 120.67 |
121.89
|
110.93
|
170.01K | -8.43% | ||||
Feb 16 | 122.54 | 122.31 |
124.72
|
120.29
|
113.89K | -0.92% | ||||
Feb 15 | 123.68 | 121.38 |
124.45
|
120.45
|
99.68K | 2.91% | ||||
Feb 14 | 120.18 | 121.60 |
123.10
|
119.37
|
104.17K | -0.31% | ||||
Feb 11 | 120.55 | 120.55 |
124.56
|
119.00
|
163.74K | 0.96% | ||||
Feb 10 | 119.40 | 122.22 |
128.51
|
118.72
|
169.93K | -4.59% | ||||
Feb 9 | 125.14 | 124.68 |
126.76
|
123.50
|
202.36K | 1.44% | ||||
Feb 8 | 123.36 | 123.59 |
125.51
|
121.47
|
72.10K | -0.55% | ||||
Feb 7 | 124.04 | 118.57 |
124.79
|
118.57
|
83.76K | 4.30% |